OpenVSafe by OpenVAERS
Search V-safe

2VL-33665-16670

2 vaccinations 7 coded responses 21 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
897 / NV
Registered
2021-01-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1091986 (opens in a new window) high 10 / 11 — 1 of 3 VAERS symptoms same dose (1) NV matches 2021-01-09 / 2021-01-11 / 2021-03-11
received the same day as the last call
 case 41372

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-01-09
    Registered in v-safe
  2. 2021-01-09
    Dose 1 — Moderna
  3. 2021-01-09
    Survey response — 0 day, dose 1
    MedDRA: Pre-existing disease, Wheezing — Feeling: Good · Site: Pain · Headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  4. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-01-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abnormal uterine bleeding, Vaginal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea, Abdominal pain
    Adult check-in
  9. 2021-01-16
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-23
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-30
    Health check-in — 21 day, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-06
    Dose 2 — Moderna
  13. 2021-02-06
    Survey response — 0 day, dose 2
    MedDRA: Abortion spontaneous, Exposure during pregnancy — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  14. 2021-02-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abortion spontaneous, Immediate post-injection reaction — Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  15. 2021-02-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  16. 2021-02-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysmenorrhoea, Menstrual disorder — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  17. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abortion spontaneous, Dysmenorrhoea, Menstruation irregular — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  18. 2021-02-13
    Health check-in — 7 day, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-20
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-01
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-06
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Call successful
    Completed over the phone
  23. 2021-03-13
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-20
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-08
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-02-08
    Health check-in — 12 month, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-09Moderna
22021-02-06Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-01-11 Successful
2021-03-11
 Completed over the phone

Free text

Release 1

Systemic reaction (other): Wheezing (However, I'm already asthmatic)
Systemic reaction (other): Unexpected menstrual bleeding/ vaginal bleeding

Release 3

Systemic reaction (other): Confirmed miscarriage within the week after the first dose
Systemic reaction (other): Confirmed miscarriage within week of 1st dose
Systemic reaction (other): Menstrual spotting
Systemic reaction (other): Unexpected menstrual cramping and bleeding

Release 4

Systemic reaction (other): Unexpected menstrual bleeding and cramping; confirmed miscarriage within week of 1st dose

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAbnormal uterine bleeding ✓ ✓ ✓
SROAbortion spontaneous ✓ ✓ ✓
SRODysmenorrhoea ✓ ✓ ✓
SROExposure during pregnancy ✓ ✓ ✓
SROImmediate post-injection reaction ✓ ✓ ✓
SROIntermenstrual bleeding ✓ ✓ ✓
SROMenstrual disorder ✓ ✓ ✓
SROMenstruation irregular ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ○ ○ ○
SROVaginal haemorrhage ✓ ✓ ✓
SROWheezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…